Help on the way for lung cancer patients
Hundreds of families across Australia will save close to $90,000 each year from a $96 million investment our Government is making to ensure lung cancer medicine is affordable. Help is on the way for around 400 patients diagnosed with lung cancer with our Government listing Tagrisso® (Osimertinib) on the Pharmaceutical Benefits Scheme (PBS) from 1 February. Patients would pay…